Almorexant

Generic Name
Almorexant
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C29H31F3N2O3
CAS Number
871224-64-5
Unique Ingredient Identifier
9KCW39P2EI
Indication

Investigated for use/treatment in sleep disorders and insomnia.

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance

Not Applicable
Completed
Conditions
Healthy Volunteers
Interventions
Drug: Zolpidem 10mg
Drug: Placebo
Drug: Almorexant
First Posted Date
2010-11-18
Last Posted Date
2014-10-06
Lead Sponsor
Northern California Institute of Research and Education
Target Recruit Count
203
Registration Number
NCT01243060
Locations
๐Ÿ‡บ๐Ÿ‡ธ

San Francisco Veterans Affairs Medical Center, San Francisco, California, United States

Almorexant in Primary Insomnia

Phase 1
Completed
Conditions
Insomnia
Primary Insomnia
Interventions
Drug: almorexant
First Posted Date
2008-03-21
Last Posted Date
2016-02-12
Lead Sponsor
Midnight Pharma, LLC
Target Recruit Count
161
Registration Number
NCT00640848
Locations
๐Ÿ‡ฆ๐Ÿ‡น

The Siesta Group, Vienna, Austria

๐Ÿ‡ฆ๐Ÿ‡น

Medical University of Vienna, University Clinic of Psychiatrie, Vienna, Austria

๐Ÿ‡ซ๐Ÿ‡ฎ

Skogby Sleep Clinic, Espoo, Finland

and more 24 locations

Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia

First Posted Date
2008-02-06
Last Posted Date
2016-03-14
Lead Sponsor
Midnight Pharma, LLC
Target Recruit Count
709
Registration Number
NCT00608985
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

The Woolcock Institute of Medical Research, Glebe, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Australian Clinical Research Organisation, Kippa Ring, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Melbourne Sleep Disorder Centre, Melbourne, Australia

and more 87 locations
ยฉ Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy